An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors

Published on Mar 21, 2020in Expert Opinion on Drug Metabolism & Toxicology4.481
· DOI :10.1080/17425255.2020.1743679
Claudiu T. Supuran155
Estimated H-index: 155
(UniFI: University of Florence)
Sources
Abstract
Introduction. Carbonic anhydrase inhibitors (CAIs) have been in clinical use for decades for the management of various disorders. An update on their drug-drug interactions is presented here considering these main therapeutic areas and drugs: glaucoma (acetazolamide, methazolamide, dichlorophenamide, dorzolamide and brinzolamide); epilepsy/obesity (sulthiame, topiramate and zonisamide); arthritis/inflammation (celecoxib and polmacoxib) and hypoxic tumors (SLC-0111).Areas covered. Drug interactions reported between CAIs with various other pharmacological agents are reviewed in publications after 2016, when the previous review was published. Most reported interactions concern the antiepileptics sulthiame, topiramate and zonisamide, as they are part of complex regimens in which drugs controlling this disorder are administered. Fewer interactions were reported for the anti-glaucoma agents, whereas synergistic combinations of celecoxib with antibiotics or SLC-0111 with various antitumor drugs were extensively investigated.Expert opinion. Drug interactions involving CAIs may be used both for monitoring the clinical efficacy of these agents when co-administered with other drugs but also for better controlling some diseases, such as hypoxic tumors, case for which the combination of CAIs with other anticancer agents (histone deacetylase inhibitors, alkylating agents, antimetabolite nucleosides, angiogenesis inhibitors and immune check point inhibitors) proved to be synergistic.
📖 Papers frequently viewed together
2002
3 Authors (徐岩, ..., 陈祖基)
References113
Newest
Abstract Epilepsy is a complex network phenomenon that, as yet, cannot be prevented or cured. We recently proposed network-based approaches to prevent epileptogenesis. For proof of concept we combined two drugs (levetiracetam and topiramate) for which in silico analysis of drug-protein interaction networks indicated a synergistic effect on a large functional network of epilepsy-relevant proteins. Using the intrahippocampal kainate mouse model of temporal lobe epilepsy, the drug combination was a...
Source
#1Elena Andreucci (UniFI: University of Florence)H-Index: 18
#2Jessica Ruzzolini (UniFI: University of Florence)H-Index: 12
Last. Lido Calorini (UniFI: University of Florence)H-Index: 31
view all 8 authors...
AbstractDrug combination represents one of the most accredited strategies of cancer therapy able to improve drug efficacy and possibly overcome drug resistance. Among the agents used to complement ...
Source
#1Gajapati Y. N. Varma (University of Hyderabad)H-Index: 2
#2Githavani Kummari (University of Hyderabad)H-Index: 2
Last. Arunasree M. Kalle (University of Hyderabad)H-Index: 19
view all 4 authors...
BACKGROUND: We have shown previously that celecoxib enhances the antibacterial effect of antibiotics and has sensitized drug-resistant bacteria to antibiotics at low concentrations using in vitro and in vivo model systems and also using clinically isolated ESKAPE pathogens. OBJECTIVES: To identify the mechanism of action of celecoxib in potentiating the effect of antibiotics on bacteria. METHODS: Toxicogenomic expression analysis of Staphylococcus aureus in the presence or absence of ampicillin,...
Source
#1Brian D. Moseley (UC: University of Cincinnati)H-Index: 19
#2Christian Otoul (UCB)H-Index: 13
Last. Armel Stockis (UCB)H-Index: 32
view all 4 authors...
Abstract Objective To assess the effect of brivaracetam (BRV) on steady-state plasma concentrations of commonly prescribed antiepileptic drugs (AEDs). Methods Data were pooled from five randomized, double-blind, placebo-controlled efficacy studies (NCT00175929, NCT00175825, NCT00490035, NCT00464269, and NCT01261325) in which adults with refractory epilepsy, and receiving stable doses of 1 − 2 AEDs, initiated adjunctive treatment with BRV (or placebo) for up to 12 weeks, following a 4-8 week base...
Source
#1Katarzyna Socała (UMCS: Maria Curie-Skłodowska University)H-Index: 15
#2Elżbieta Wyska (Jagiellonian University Medical College)H-Index: 17
Last. Piotr Wlaź (UMCS: Maria Curie-Skłodowska University)H-Index: 26
view all 5 authors...
Abstract Cannabidiol and cannabidiol-enriched products have recently attracted much attention as an add-on therapy for epilepsy, especially drug-resistant seizures. It should be, however, remembered that concomitant use of cannabidiol and antiepileptic drugs may pose a risk of interactions between them. For this reason, the aim of our study was to assess the effect of cannabidiol on the activity of selected new antiepileptic drugs in the electrically-induced seizure models in mice. We studied th...
Source
#1Giosuè Costa (Magna Græcia University)H-Index: 23
#2Fabrizio Carta (UniFI: University of Florence)H-Index: 52
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 15 authors...
Abstract The human Carbonic anhydrases (hCA) VA and VB play a key role in ureagenesis, gluconeogenesis, lipogenesis and in the metabolism regulation, thus representing highly popular drug targets. Albeit several hCA inhibitors have been designed and are currently in clinical use, serious drug interactions have been reported due to their poor selectivity. In this perspective, the drug repurposing approach could be a useful tool in order to investigate the drug promiscuity/polypharmacology profile...
Source
Abstract 6A10 is a CA XII inhibitory monoclonal antibody, which was demonstrated to reduce the growth of cancer cells in vitro and in a xenograft model of lung cancer. It was also shown to enhance chemosensitivity of multiresistent cancer cell lines, and to significantly reduce the number of lung metastases in combination with doxorubicin in mice carrying human triple-negative breast cancer xenografts. Starting from these data, we report here on the development of the 6A10 antigen-binding fragme...
Source
Source
#1Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
#2Abdulmalik Saleh Alfawaz Altamimi (Salman bin Abdulaziz University)H-Index: 5
Last. Fabrizio Carta (UniFI: University of Florence)H-Index: 52
view all 3 authors...
ABSTRACTIntroduction: Glaucoma affects more than 70 million people worldwide. One of the major therapeutic options for its management is based on the inhibition of the metalloenzyme carbonic anhydr...
Source
ABSTRACTIntroduction: Macular degeneration (MD) and macular edema (ME) are ophthalmologic diseases affecting an increasing number of the aging population. Until recently, there were few therapeutic...
Source
Cited By10
Newest
#1Alessio Nocentini (UniFI: University of Florence)H-Index: 29
#2Doretta Cuffaro (UniPi: University of Pisa)H-Index: 6
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 8 authors...
The synthesis and carbonic anhydrase (CA; EC 4.2.1.1) activating effects of a series of oxime ether-based amino alcohols towards four human (h) CA isoforms expressed in human brain, hCA I, II, IV a...
Source
#1Nevio Cimolai (UBC: University of British Columbia)H-Index: 20
Acetazolamide was developed nearly 70 years ago and continues to be used for niche indications. Mechanisms of action are relatively less well-studied than clinical applications. Several potential uses span the spectrum of neurological illnesses, but yet neurological side effects complicate short- and long-term applications for many patients. This review examines the basic science and clinical usages of acetazolamide germane to neurological and psychiatric spectrums. The existing publications wer...
Source
#1Dandan Su (University of Montpellier)H-Index: 1
#2Yan Zhang (Jiangnan University)H-Index: 18
Last. Mihail Barboiu (University of Montpellier)H-Index: 51
view all 4 authors...
In this review we consider one important member of the metalloenzymes family, the carbonic anhydrase (CA), involved in the treatment of several common diseases. Different approaches have emerged to regulate the activity of CA, mostly acting on the inner catalytic active site or outer microenvironment of the enzyme, leading to inhibition or activation of CA. In recent years, gradually increased attention has focused on the adoption of constitutional dynamic chemistry (CDC) strategies for the scre...
Source
#1Francesco MincioneH-Index: 23
#2Alessio Nocentini (UniFI: University of Florence)H-Index: 29
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 3 authors...
INTRODUCTION Glaucoma, a neuropathy characterized by increased intraocular pressure (IOP), is the major cause of blindness worldwide and its treatment aims at reducing IOP. AREAS COVERED The authors review the design of the main classes of anti-glaucoma agents. Drugs which interfere with the aqueous humor secretion (adrenergic agonists/antagonists, carbonic anhydrase inhibitors) and with its outflow, by means of both conventional and non-conventional pathways (prostaglandin (PG) analogs, rho kin...
Source
#2Silvia Bua (UniFI: University of Florence)H-Index: 21
Last. Vincenzo AlterioH-Index: 22
view all 4 authors...
Abstract Up to date alcohols have been scarcely investigated as carbonic anhydrase (CA) inhibitors. To get more insights into the CA inhibition properties of this class of molecules, in this paper, by means of inhibition assays and X-ray crystallographic studies we report a detailed characterization of the CA inhibition properties and the binding mode to human CA II of benzyl alcohol. Results show that, although possessing a very simple scaffold, this molecule acts as a micromolar CA II inhibito...
Source
#1Ana Carolina Rafanhin Sousa (USP: University of São Paulo)H-Index: 1
#2Cleyton Nascimento Makara (USP: University of São Paulo)H-Index: 1
Last. Emanuel Carrilho (USP: University of São Paulo)H-Index: 46
view all 4 authors...
Abstract To increase milk production, antibiotics are administered to animals to provide weight gain and to prevent or treat diseases. The inappropriate use of these substances can lead to antibiotic resistance and allergic reactions and toxic effects to milk consumers. We describe the development of a simple, fast, portable, and low-cost microfluidic paper-based analytical device (μPAD) to quantify sulfonamides in milk using the inhibition of the colorimetric reaction between carbonic anhydrase...
Source
#1Keyvan Pedrood (Tehran University of Medical Sciences)H-Index: 3
#2Maedeh Sherafati (Tehran University of Medical Sciences)H-Index: 3
Last. İlhami Gülçin (Atatürk University)H-Index: 103
view all 12 authors...
Abstract In this study, novel quinazolinone derivatives 7a-n were synthesized and evaluated against metabolic enzymes α-glycosidase, acetylcholinesterase, butyrylcholinesterase, human carbonic anhydrase I, and II. These compounds exhibited high inhibitory activities in comparison to used standard inhibitors with Ki values in the range of 19.28–135.88 nM for α-glycosidase (Ki value for standard inhibitor = 187.71 nM), 0.68–23.01 nM for acetylcholinesterase (Ki value for standard inhibitor = 53.31...
Source
#1Mercedes Serrano (ISCIII: Carlos III Health Institute)H-Index: 23
Phosphomannomutase 2 deficiency (PMM2-CDG) is the most frequent congenital disorder of glycosylation. PMM2-CDG patients develop chronic cerebellar atrophy as a neurological hallmark. However, other acute neurological phenomena such as stroke-like episodes (SLE), epilepsy, migraine, and cerebrovascular events, may also occur, and they are frequently the cause of disability and impaired quality of life. Among these, SLE are among the most stressful situations for families and doctors, as their ris...
Source
#1Belgin Sever (Anadolu University)H-Index: 12
#2Cüneyt TürkeşH-Index: 21
Last. Sükrü Beydemir (Bilecik Şeyh Edebali University)H-Index: 52
view all 5 authors...
Abstract Alzheimer's disease (AD) is a complex, predominant, and progressive form of dementia. The treatment of AD alters depending on the cognitive and behavioral symptoms. The utility of cholinergic replacement by acetylcholinesterase (AChE) inhibitors in AD treatment has been well-documented so far. Recent studies have also demonstrated that human carbonic anhydrases (hCAs) serve as important targets for AD treatment. In an attempt to identify potent AChE and hCA inhibitors, new thiazolyl-pyr...
Source
#1Pavitra S. ThackerH-Index: 5
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 8 authors...
Abstract Two series, coumarin-linked to thiazolidinone via a pyrazole linker (6a-m, Series 1) and coumarin-linked 1,2,3-triazoles (5a-j, Series 2) were synthesized and the synthesized compounds were subjected for evaluation against the four physiologically and pharmacologically relevant hCA isoforms, hCA I, II, IX and XII. The results indicated selective inhibition of tumor-associated isoforms hCA IX and XII over the off-target isoforms, hCA I and II. The compounds of series 1 exhibited better h...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.